nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—XDH—Purine catabolism—GPX1—head and neck cancer	0.0403	0.1	CbGpPWpGaD
Pyrazinamide—Peptic ulcer—Vinblastine—head and neck cancer	0.0398	0.0667	CcSEcCtD
Pyrazinamide—Digestion impaired—Hydroxyurea—head and neck cancer	0.0363	0.0608	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.0314	0.0527	CcSEcCtD
Pyrazinamide—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.027	0.0669	CbGpPWpGaD
Pyrazinamide—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.0262	0.0438	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.0247	0.0414	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0221	0.037	CcSEcCtD
Pyrazinamide—XDH—Oxidative Stress—SOD2—head and neck cancer	0.0175	0.0435	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—GPX1—head and neck cancer	0.0167	0.0415	CbGpPWpGaD
Pyrazinamide—XDH—Oxidative Stress—CYP1A1—head and neck cancer	0.0166	0.0411	CbGpPWpGaD
Pyrazinamide—Hepatotoxicity—Docetaxel—head and neck cancer	0.0163	0.0274	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Fluorouracil—head and neck cancer	0.0159	0.0266	CcSEcCtD
Pyrazinamide—XDH—Purine metabolism—GPX1—head and neck cancer	0.0155	0.0385	CbGpPWpGaD
Pyrazinamide—XDH—Nucleotide metabolism—DPYD—head and neck cancer	0.0144	0.0358	CbGpPWpGaD
Pyrazinamide—Photosensitivity—Fluorouracil—head and neck cancer	0.0144	0.0242	CcSEcCtD
Pyrazinamide—Dysuria—Hydroxyurea—head and neck cancer	0.0142	0.0239	CcSEcCtD
Pyrazinamide—AOX1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.0127	0.0314	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.0118	0.0292	CbGpPWpGaD
Pyrazinamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.0108	0.0181	CcSEcCtD
Pyrazinamide—Malaise—Vinblastine—head and neck cancer	0.0105	0.0176	CcSEcCtD
Pyrazinamide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.01	0.0249	CbGpPWpGaD
Pyrazinamide—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.01	0.0168	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00985	0.0165	CcSEcCtD
Pyrazinamide—Discomfort—Vinblastine—head and neck cancer	0.00979	0.0164	CcSEcCtD
Pyrazinamide—Malaise—Hydroxyurea—head and neck cancer	0.00957	0.016	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Vinblastine—head and neck cancer	0.0093	0.0156	CcSEcCtD
Pyrazinamide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00913	0.0227	CbGpPWpGaD
Pyrazinamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00909	0.0225	CbGpPWpGaD
Pyrazinamide—Anorexia—Vinblastine—head and neck cancer	0.00905	0.0152	CcSEcCtD
Pyrazinamide—Discomfort—Hydroxyurea—head and neck cancer	0.00893	0.015	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00848	0.0142	CcSEcCtD
Pyrazinamide—Anorexia—Hydroxyurea—head and neck cancer	0.00825	0.0138	CcSEcCtD
Pyrazinamide—Decreased appetite—Vinblastine—head and neck cancer	0.00825	0.0138	CcSEcCtD
Pyrazinamide—XDH—Nucleotide metabolism—TYMS—head and neck cancer	0.00823	0.0204	CbGpPWpGaD
Pyrazinamide—Feeling abnormal—Vinblastine—head and neck cancer	0.00783	0.0131	CcSEcCtD
Pyrazinamide—XDH—Nucleotide metabolism—GPX1—head and neck cancer	0.00779	0.0193	CbGpPWpGaD
Pyrazinamide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00762	0.0128	CcSEcCtD
Pyrazinamide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00753	0.0126	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00748	0.0125	CcSEcCtD
Pyrazinamide—XDH—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00742	0.0184	CbGpPWpGaD
Pyrazinamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00714	0.012	CcSEcCtD
Pyrazinamide—XDH—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00707	0.0176	CbGpPWpGaD
Pyrazinamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00705	0.0175	CbGpPWpGaD
Pyrazinamide—Hypersensitivity—Vinblastine—head and neck cancer	0.007	0.0117	CcSEcCtD
Pyrazinamide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00685	0.0115	CcSEcCtD
Pyrazinamide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.0068	0.0169	CbGpPWpGaD
Pyrazinamide—Myalgia—Fluorouracil—head and neck cancer	0.0065	0.0109	CcSEcCtD
Pyrazinamide—Discomfort—Fluorouracil—head and neck cancer	0.00642	0.0108	CcSEcCtD
Pyrazinamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00638	0.0107	CcSEcCtD
Pyrazinamide—Hepatitis—Docetaxel—head and neck cancer	0.00633	0.0106	CcSEcCtD
Pyrazinamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00616	0.0153	CbGpPWpGaD
Pyrazinamide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0061	0.0102	CcSEcCtD
Pyrazinamide—Vomiting—Vinblastine—head and neck cancer	0.00604	0.0101	CcSEcCtD
Pyrazinamide—Anorexia—Fluorouracil—head and neck cancer	0.00594	0.00995	CcSEcCtD
Pyrazinamide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00576	0.0143	CbGpPWpGaD
Pyrazinamide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00568	0.00951	CcSEcCtD
Pyrazinamide—Nausea—Vinblastine—head and neck cancer	0.00564	0.00945	CcSEcCtD
Pyrazinamide—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00553	0.0137	CbGpPWpGaD
Pyrazinamide—Vomiting—Hydroxyurea—head and neck cancer	0.00551	0.00922	CcSEcCtD
Pyrazinamide—Dyspepsia—Fluorouracil—head and neck cancer	0.00549	0.00919	CcSEcCtD
Pyrazinamide—Rash—Hydroxyurea—head and neck cancer	0.00546	0.00915	CcSEcCtD
Pyrazinamide—Dermatitis—Hydroxyurea—head and neck cancer	0.00546	0.00914	CcSEcCtD
Pyrazinamide—Decreased appetite—Fluorouracil—head and neck cancer	0.00542	0.00908	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00538	0.00901	CcSEcCtD
Pyrazinamide—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.00524	0.013	CbGpPWpGaD
Pyrazinamide—Nausea—Hydroxyurea—head and neck cancer	0.00514	0.00862	CcSEcCtD
Pyrazinamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00514	0.0086	CcSEcCtD
Pyrazinamide—Urticaria—Fluorouracil—head and neck cancer	0.00495	0.0083	CcSEcCtD
Pyrazinamide—Body temperature increased—Fluorouracil—head and neck cancer	0.00493	0.00825	CcSEcCtD
Pyrazinamide—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00482	0.012	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00475	0.0118	CbGpPWpGaD
Pyrazinamide—Myalgia—Docetaxel—head and neck cancer	0.00469	0.00786	CcSEcCtD
Pyrazinamide—Arthralgia—Docetaxel—head and neck cancer	0.00469	0.00786	CcSEcCtD
Pyrazinamide—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00463	0.0115	CbGpPWpGaD
Pyrazinamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.00459	0.00769	CcSEcCtD
Pyrazinamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.00452	0.0112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00445	0.011	CbGpPWpGaD
Pyrazinamide—Pruritus—Fluorouracil—head and neck cancer	0.00441	0.00739	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Docetaxel—head and neck cancer	0.00441	0.00738	CcSEcCtD
Pyrazinamide—Anorexia—Docetaxel—head and neck cancer	0.00429	0.00718	CcSEcCtD
Pyrazinamide—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00427	0.0106	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00416	0.0103	CbGpPWpGaD
Pyrazinamide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0041	0.00687	CcSEcCtD
Pyrazinamide—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00405	0.01	CbGpPWpGaD
Pyrazinamide—Vomiting—Fluorouracil—head and neck cancer	0.00396	0.00664	CcSEcCtD
Pyrazinamide—Dyspepsia—Docetaxel—head and neck cancer	0.00396	0.00663	CcSEcCtD
Pyrazinamide—Rash—Fluorouracil—head and neck cancer	0.00393	0.00658	CcSEcCtD
Pyrazinamide—Dermatitis—Fluorouracil—head and neck cancer	0.00393	0.00658	CcSEcCtD
Pyrazinamide—Decreased appetite—Docetaxel—head and neck cancer	0.00391	0.00655	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00388	0.00651	CcSEcCtD
Pyrazinamide—AOX1—Metabolism—UROD—head and neck cancer	0.00388	0.00962	CbGpPWpGaD
Pyrazinamide—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00372	0.00923	CbGpPWpGaD
Pyrazinamide—Feeling abnormal—Docetaxel—head and neck cancer	0.00371	0.00621	CcSEcCtD
Pyrazinamide—Nausea—Fluorouracil—head and neck cancer	0.0037	0.0062	CcSEcCtD
Pyrazinamide—XDH—Metabolism—UROD—head and neck cancer	0.0036	0.00894	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00358	0.00888	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00358	0.00888	CbGpPWpGaD
Pyrazinamide—Body temperature increased—Docetaxel—head and neck cancer	0.00356	0.00596	CcSEcCtD
Pyrazinamide—Hypersensitivity—Docetaxel—head and neck cancer	0.00331	0.00555	CcSEcCtD
Pyrazinamide—Pruritus—Docetaxel—head and neck cancer	0.00318	0.00533	CcSEcCtD
Pyrazinamide—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00316	0.00783	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.00315	0.00781	CbGpPWpGaD
Pyrazinamide—Vomiting—Docetaxel—head and neck cancer	0.00286	0.00479	CcSEcCtD
Pyrazinamide—Rash—Docetaxel—head and neck cancer	0.00284	0.00475	CcSEcCtD
Pyrazinamide—Dermatitis—Docetaxel—head and neck cancer	0.00283	0.00475	CcSEcCtD
Pyrazinamide—Nausea—Docetaxel—head and neck cancer	0.00267	0.00448	CcSEcCtD
Pyrazinamide—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00248	0.00614	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00248	0.00614	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00248	0.00614	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00234	0.0058	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00232	0.00575	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.002	0.00497	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00197	0.0049	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00191	0.00474	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.00184	0.00457	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.00182	0.0045	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00162	0.00403	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NAT2—head and neck cancer	0.00161	0.00399	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.00155	0.00386	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00154	0.00383	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00152	0.00378	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NAT2—head and neck cancer	0.0015	0.00371	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00147	0.00365	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00142	0.00352	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—DPYD—head and neck cancer	0.00141	0.0035	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.0014	0.00348	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00138	0.00342	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00136	0.00339	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—YAP1—head and neck cancer	0.00134	0.00332	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—DPYD—head and neck cancer	0.00131	0.00326	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00125	0.00311	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—YAP1—head and neck cancer	0.00125	0.00309	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00116	0.00288	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00104	0.00259	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00104	0.00259	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00104	0.00259	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000909	0.00226	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000897	0.00222	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000862	0.00214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00085	0.00211	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000838	0.00208	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TYMS—head and neck cancer	0.000804	0.002	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—head and neck cancer	0.000795	0.00197	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GPX1—head and neck cancer	0.000761	0.00189	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UROD—head and neck cancer	0.000758	0.00188	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1A1—head and neck cancer	0.000754	0.00187	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TYMS—head and neck cancer	0.000748	0.00186	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—head and neck cancer	0.000739	0.00183	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOTCH1—head and neck cancer	0.000721	0.00179	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GPX1—head and neck cancer	0.000708	0.00176	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000702	0.00174	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1A1—head and neck cancer	0.000701	0.00174	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000692	0.00172	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000665	0.00165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000656	0.00163	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000588	0.00146	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UROD—head and neck cancer	0.000585	0.00145	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—head and neck cancer	0.000535	0.00133	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTEN—head and neck cancer	0.000467	0.00116	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—head and neck cancer	0.000448	0.00111	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—head and neck cancer	0.000417	0.00104	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—head and neck cancer	0.000417	0.00103	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—head and neck cancer	0.000399	0.000989	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTEN—head and neck cancer	0.000391	0.00097	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK1—head and neck cancer	0.000379	0.000941	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—head and neck cancer	0.000379	0.000941	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTEN—head and neck cancer	0.000363	0.000902	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000334	0.000829	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000331	0.000821	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—head and neck cancer	0.000329	0.000817	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NAT2—head and neck cancer	0.000315	0.000781	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HRAS—head and neck cancer	0.000305	0.000756	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DPYD—head and neck cancer	0.000276	0.000685	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—head and neck cancer	0.000276	0.000684	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—head and neck cancer	0.000269	0.000667	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—YAP1—head and neck cancer	0.000262	0.00065	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—head and neck cancer	0.000256	0.000636	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NAT2—head and neck cancer	0.000243	0.000603	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—head and neck cancer	0.000225	0.000559	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DPYD—head and neck cancer	0.000213	0.000529	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—head and neck cancer	0.000209	0.00052	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—YAP1—head and neck cancer	0.000202	0.000502	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000197	0.000488	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000172	0.000426	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TYMS—head and neck cancer	0.000157	0.00039	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—head and neck cancer	0.000155	0.000386	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—head and neck cancer	0.000149	0.000369	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1A1—head and neck cancer	0.000147	0.000366	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TYMS—head and neck cancer	0.000121	0.000301	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000121	0.0003	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—head and neck cancer	0.00012	0.000298	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—head and neck cancer	0.000115	0.000285	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	0.000114	0.000282	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—head and neck cancer	8.76e-05	0.000217	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTEN—head and neck cancer	7.64e-05	0.00019	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.76e-05	0.000168	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTEN—head and neck cancer	5.9e-05	0.000146	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.39e-05	0.000134	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—head and neck cancer	4.4e-05	0.000109	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.16e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—head and neck cancer	3.4e-05	8.43e-05	CbGpPWpGaD
